glp-1 receptor medications Agonists: The New Wave in Diabetes Management Mapping the effectiveness and risks

Bile acids induce glucagon-like peptide 2 secretion with limited effects on intestinal adaptation in early weaned pigs

have a Cooperative Research and Development Agreement to develop exendin-4 (exenatide) as a treatment strategy for neurodegenerative disorders for which NIA and Peptron Inc

At ChemOutsourcing 2025, one of the most anticipated discussions of the week explored how Indias CDMO sector is transforming from a cost-driven supplier to a strategic global manufacturing hub

Glucagon-like peptide (GLP-1) is involved in the central modulation of fecal output in rats

It has become the focus of intense pharmaceutical development, resulting in numerous FDA-approved drugs for diabetes and obesity

Acute sitagliptin administration to chow-fed mice significantly reduces plasma cholesterol and TG at 90 min post-triton infusion and oil gavage (Hsieh et al., 2010)